Capecitabine in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die.
PURPOSE: Phase II trial to study the effectiveness of capecitabine in treating patients who
have advanced, persistent, or recurrent cervical cancer.